According to KFF’s research, the new Trump executive order on small molecule drugs could lead to higher Medicare prescription drug prices and potentially higher Medicare Part D premiums.
Medicare Executive Order Boosts Drug Industry’s Profits as Seniors Suffer: Report
The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA) Medicare negotiation program, putting Medicare and beneficiary savings at risk.
Medicare Part B vs. Medicare Part D Drugs
What do I need to know about the difference between Part D and Part B medications?
Will Trump Pitch Sweeping Medicare Part D Prescription Price Plan?
POLITICO reports Trump wanted the ‘most favored nation’ policy in his first term but faced resistance from the pharmaceutical industry and the courts.